遗传性血小板功能障碍的分子病变
Agustín Rodríguez-Alén1, Antonio Moscardó2, José M Bastida3
1Servicio de Hematología, Hospital Universitario de Toledo, 45007 Toledo, Spain.
Biomolecules
|November 27, 2025
概括
遗传性血小板功能障碍 (IPFD) 涉及导致血小板功能异常的遗传缺陷,导致出血. 基因测序方面的进步改善了诊断,并为这些疾病揭示了新的治疗点.
科学领域:
- 血液学 血液学 血液学
- 分子遗传学 分子遗传学
- 人体生理学 人体生理学
背景情况:
- 遗传性血小板功能障碍 (IPFD) 是一种遗传性疾病,血小板数量正常,但功能受损.
- 格兰兹曼血栓塞,一个关键的IPFD,源于对αIIbβ3整合素复合物的基因突变,导致严重出血.
- IPFD的范围包括血小板受体,信号蛋白和颗粒生物发生的缺陷.
研究的目的:
- 审查IPFDs的分子基础,临床特征和管理.
- 突出先进的测序技术对IPFD诊断和理解的影响.
- 讨论新兴的治疗策略及其对血小板生物学的影响.
主要方法:
- 对IPFDs的当前文献的审查.
- 对遗传变异的分析及其与临床表型的相关性.
- 检查诊断和治疗方面的进展.
主要成果:
- 分子遗传学已经确定了许多与IPFD相关的基因,这些基因超出了Glanzmann的血栓形成障碍.
- 高通量测序显著提高了诊断准确性和基因型-表型相关性.
- 目前的治疗包括抗纤维解药,德斯莫普林素和血小板输血,基因疗法和双特异性抗体是新兴的选择.
结论:
- 了解IPFD分子病原体对于准确的诊断和有效的治疗至关重要.
- 先进的遗传工具正在彻底改变对血小板功能障碍的研究和管理.
- 未来的研究方向包括基因疗法和基于抗体的新疗法,以改善患者的治疗结果.
相关概念视频
01:22Formation of the Platelet Plug
8.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.6K
01:18Structure and Function of Platelets
2.8K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.8K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
01:24Disorders of Hemostasis
2.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.0K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
11.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.9K